Subscription of convertible notes in AimBiotech by Wavemaker
Allen & Gledhill, as transaction counsel, advised Wavemaker Pacific 3, L.P. (“Wavemaker”), a venture capital firm, who led a convertible note investment in AimBiotech.
AimBiotech is a biotechnology start-up focused on leading the shift from preclinical animal models to humanised in vitro physiological models for the discovery of new medicines.
Advising Wavemaker was Allen & Gledhill Partner Nicholas Soh.
